Table: Phoenixbio - 9-MTH group results

PhoenixBio

14/02/2023 06:30

Feb 14 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               1.66               933 mln           2.02     
                   (+77.9 pct)                          (+52.6 pct) 
  Operating          464 mln          loss 172 mln        332 mln   
  Recurring          446 mln          loss 158 mln        325 mln   
  Net                393 mln          loss 161 mln        281 mln   
  EPS              117.70 yen        loss 49.01 yen      83.52 yen  
  EPS Diluted       78.09 yen                                       
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T